Company Filing History:
Years Active: 1996-1998
Title: Richard Eberle: Innovator in Herpes B Virus Detection
Introduction
Richard Eberle is a notable inventor based in Stillwater, OK (US). He has made significant contributions to the field of biomedical research, particularly in the detection of the monkey herpes B virus. With a total of 2 patents, his work has implications for both human and animal health.
Latest Patents
Eberle's latest patents focus on methods for the early detection of the monkey herpes B virus. One patent details the DNA sequence (SEQ ID NO:4) of the monkey B virus, which codes for the gB glycoprotein (UL27) and a portion (UL28) of an ICP 18.5 kilodalton polypeptide (UL28). This method allows for the amplification of primer sequences to distinguish monkey B virus DNA from other herpes virus gB DNA using unique reaction conditions. Another patent outlines a similar method for the detection of the herpes B virus, emphasizing the importance of unequivocal differentiation in diagnostic processes.
Career Highlights
Richard Eberle is affiliated with the Southwest Foundation for Biomedical Research, where he continues to advance his research in viral detection. His work is critical in developing reliable methods for identifying the presence of the monkey herpes B virus, which can pose serious health risks.
Collaborations
Eberle collaborates with esteemed colleagues, including Darla Black and Franco Scinicariello. Their combined expertise enhances the research efforts at the Southwest Foundation for Biomedical Research.
Conclusion
Richard Eberle's innovative work in the detection of the monkey herpes B virus showcases his commitment to advancing biomedical research. His patents contribute significantly to the field and have the potential to improve health outcomes for both humans and monkeys.